Illumina, Inc.
ILMN
Rang in aandelen
#602
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Aandeelprijs
$268.04
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$40.47B
Verandering (1 dag)
2.05%
Verandering (1 jaar)
170.86%
Land
US
Handel Illumina, Inc. (ILMN)
Categorie
Healthcare
Omzet van Illumina, Inc. (ILMN)
Omzet in Jun 2026 TTM: $4.49B
Volgens de laatste financiële rapporten van Illumina, Inc. bedraagt de huidige omzet van het bedrijf (TTM) $4.49B. In 2024 behaalde het bedrijf een omzet van $4.37B een daling ten opzichte van de omzet in het jaar 2023, die $4.50B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van Illumina, Inc. van 2000 tot 2026
Omzet aan het einde van elk jaar
| Jaar | Omzet | Wijzigen |
|---|---|---|
| 2026 (TTM) | $4.49B | 3.48% |
| 2025 | $4.34B | -0.69% |
| 2024 | $4.37B | -2.93% |
| 2023 | $4.50B | -0.49% |
| 2022 | $4.53B | 39.73% |
| 2021 | $3.24B | -8.58% |
| 2019 | $3.54B | 6.30% |
| 2018 | $3.33B | 21.11% |
| 2017 | $2.75B | 14.74% |
| 2016 | $2.40B | 8.05% |
| 2015 | $2.22B | 19.25% |
| 2014 | $1.86B | 30.97% |
| 2013 | $1.42B | 23.74% |
| 2012 | $1.15B | 8.81% |
| 2011 | $1.06B | 16.93% |
| 2010 | $902.74M | 35.48% |
| 2009 | $666.32M | 16.24% |
| 2008 | $573.23M | 56.28% |
| 2007 | $366.80M | 98.71% |
| 2006 | $184.59M | 151.13% |
| 2005 | $73.50M | 45.31% |
| 2004 | $50.58M | 80.43% |
| 2003 | $28.04M | 179.23% |
| 2002 | $10.04M | 303.86% |
| 2001 | $2.49M | 89.90% |
| 2000 | $1.31M | 0.00% |
Omzet van vergelijkbare bedrijven of concurrenten
| Bedrijf | Omzet | Omzetverschil | Land |
|---|---|---|---|
| $46.34B | 931.29% |
US
|
|
| $25.11B | 458.80% |
US
|
|
| $2.71B | -39.75% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 64.08% |
US
|
